24 Feb 2015

DIGITALEUROPE Statement WHO Recommendation to add GBL and BDO to Schedule I Psychotropic Substances Convention

DIGITALEUROPE Statement WHO Recommendation to add GBL and BDO to Schedule I Psychotropic Substances Convention

We strongly urge EU Member States which are also Members of the United Nations Commission on Narcotic Drugs (CND) to vote against the listing of Gammabutyrolactone (GBL) (CAS No. 96-48-0) and 1,4-butanediol (BDO) (CAS No 110-63-4) on the Convention on Psychotropic Substances at the Vote of the CND that will take place on 13 March in Vienna.

The World Health Organization (WHO) has recommended to the United Nations Commission on Narcotic Substances that both GBL and BDO be added to Schedule I of the 1971 Convention on Psychotropic Substances. Both GBL and BDO are widely used industrial chemicals, including in the information and communications technology (ICT) and electronics industry and its global supply chain. If this recommendation is approved at an upcoming meeting of this Convention, the use of these chemicals would be restricted to certain scientific and medical uses and the ICT industry would effectively be prohibited from continuing legitimate uses of these substances critical to the manufacture of its products. Countries should ensure that GBL and BDO are not listed under the 1971 Convention on Psychotropic Substances.

Back to Sustainability
View the complete Policy Paper
PDF
Our resources on Sustainability
Policy Paper 26 Jul 2019
Joint industry comments on modulating producers’ financial contributions for Waste Electrical and Electronic Equipment
Publication & Brochure 12 Jun 2019
Digitalisation as key for a sustainable Europe - our Call to Action for the EU's Strategic Agenda 2019-2024
Policy Paper 24 May 2019
Key recommendations for the development of the SVHC database by ECHA
Hit enter to search or ESC to close